AstraZeneca Pharma loses patent plea; stock slips 6%

AstraZeneca Pharma  lost patent plea on its cancer drug to 2 domestic company including Natco pharma, reports CNBC-TV18.
 
At 09:31 hrs AstraZeneca Pharma was quoting at Rs 1,460.05, down Rs 105.10, or 6.72%. It has touched an intraday high of Rs 1,525 and an intraday low of Rs 1,449.50. 
 
It was trading with volumes of 4,850 shares. In the previous trading session, the share closed up 2.98% or Rs 45.30 at Rs 1,565.15.

The share touched its 52-week high Rs 2,649 and 52-week low Rs 1,240 on 12 April, 2012 and 29 December, 2011, respectively. Currently, it is trading 44.88% below its 52-week high and 17.75% above its 52-week low. Market capitalisation stands at Rs 3,650.13 crore.

The company's trailing 12-month (TTM) EPS was at Rs 24.61 per share. (Sep, 2012). The stock's price-to-earnings (P/E) ratio was 59.53. The latest book value of the company is Rs 75.71 per share. At current value, the price-to-book value of the company was 19.35. The dividend yield of the company was 0.24%.